Question follow-through · 5502

Palforzia

To ask the Secretary of State for Health and Social Care, what the NHS geographic availability is of Palforzia as of September 2024; and if he will publish a regional breakdown the number of people that received Palforzia on the NHS since 2022.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
11 Sept 2024
Target answer date
7 Oct 2024
Answer
8 Oct 2024 · 27 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 11 Sept 2024

    Question tabled

    To ask the Secretary of State for Health and Social Care, what the NHS geographic availability is of Palforzia as of September 2024; and if he will publish a regional breakdown the number of people that received Palforzia on the NHS since 2022.

  2. 7 Oct 2024

    Target answer date

    Date supplied by the official written-questions record.

  3. 8 Oct 2024

    Answer published

    Palforzia is a peanut immunotherapy drug that helps reduce the severity of children's allergic reactions that may occur with exposure to peanuts. Data on the number and geographical location of children that have had access to Palforzia in England is not ...

Open official record

Official data retrieved 27 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medical Equipment: Standards

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, with reference to the report by Lord Darzi entitled Independent investigation of the NHS in England, published on 12 September 2024, what steps he plans to take to improve the quality of the NHS eq

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, whether he plans to take steps with NHS England to develop (a) modelling of the blood cancer care workforce and (b) national standards for staffing and facilities.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer: Nurses

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, how many (a) blood cancer clinical nurses employed and (b) vacant blood cancer clinical nurse specialist posts there are in the NHS; and what assessment he has made of the potential merits of devel

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer: Diagnosis

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, what steps he is taking improve the disparities experienced by those from (a) ethnic minorities, (b) deprived backgrounds and (c) geographically remote locations in accessing a timely diagnosis of

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) help improve patient understanding of self-monitoring of blood cancer and (b) increase funding for (i) sign-posting and referrals into charity support services and (i

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer: Clinical Trials

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to support (a) investigator-led and (b) commercially-sponsored clinical trials in blood cancer research.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer: Clinical Trials

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of participation in clinical trials for blood cancer; and whether he plans to take steps to increase the level of participation among underreprese

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, if he will take steps to hold discussions with his counterparts in the devolved Administrations on co-ordinating national cancer registries in their (a) collection, (b) analysis and (c) reporting o

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Blood Cancer

12 Sept 2024 · To ask the Secretary of State for Health and Social Care, if he will take steps to help ensure blood cancer is routinely included as a distinct category when reporting on (a) prevalence, (b) healthcare utilisation and (c) other appropriate benchmarks.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Trastuzumab Deruxtecan: Northern Ireland

4 Oct 2024 · To ask the Secretary of State for Health and Social Care, if he will have discussions with the Northern Ireland Health Minister on access to Enhertu in Northern Ireland.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Electronic Cigarettes and Tobacco

21 Oct 2024 · To ask the Secretary of State for Health and Social Care, when he plans to introduce the Tobacco and Vapes Bill.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Radioisotopes: Northern Ireland

30 Oct 2024 · To ask the Secretary of State for Health and Social Care, what steps he is taking with his Northern Irish counterpart to ensure that radioisotopes are distributed to areas most in need.